Immunotoxicity testing guidance; availability.  Food and Drug Administration, HHS.  Notice.
The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled "Immunotoxicity Testing Guidance."  This guidance is intended to provide FDA reviewers and manufacturers with a coherent strategy for assessing whether testing for potential adverse effects involving medical devices or constituent materials and the immune system is needed.  The guidance is also intended to aid in developing a systematic approach to such testing.
D004869:Equipment Safety; D017408:Guidelines as Topic; D006801:Humans; D000922:Immunotoxins; D014481:United States; D014486:United States Food and Drug Administration
D000922:Immunotoxins